Viromed Medical AG | Finanzwire

BRIEF

published on 09/30/2025 at 11:52, 7 months 1 day ago

Viromed Medical AG Initiates Cold Plasma Study on Living Lungs

Viromed Medical AG Cold Plasma Lung Study VAP Treatment Pulmonology Research
PRESS RELEASE

published on 09/30/2025 at 11:47, 7 months 1 day ago

Viromed Medical AG launches in vivo and ex vivo study with cold plasma on living lungs
Viromed Medical AG launches in vivo and ex vivo study with cold plasma on living lungs. The study aims to revolutionize the treatment of ventilator-associated pneumonia and lung infections

Viromed Medical AG Ventilator-associated Pneumonia Cold Plasma Technology In Vivo Study Ex Vivo Study
BRIEF

published on 09/23/2025 at 11:13, 7 months 8 days ago

Viromed Medical AG Seeks Approval for PulmoPlas®

Antimicrobial Resistance Viromed Medical AG Cold Plasma Technology PulmoPlas® BfArM Approval
PRESS RELEASE

published on 09/23/2025 at 11:08, 7 months 8 days ago

Viromed Medical AG initiates approval process for PulmoPlas® with the Federal Institute for Drugs and Medical Devices (BfArM)
Viromed Medical AG initiates approval process for PulmoPlas® with the Federal Institute for Drugs and Medical Devices (BfArM), aiming to combat ventilator-associated pneumonia and antimicrobial resistance

Viromed Medical AG Ventilator-associated Pneumonia Cold Plasma Technology Approval Process PulmoPlas
BRIEF

published on 09/18/2025 at 10:28, 7 months 13 days ago

Viromed Medical AG Secures ISO 13485 Certification for ViroCAP® Launch

ISO 13485 Certification Viromed Medical AG Cold Plasma Technology ViroCAP® Launch Medical Device Manufacturer
PRESS RELEASE

published on 09/18/2025 at 10:23, 7 months 13 days ago

Viromed Medical AG: Successful ISO 13485 certification paves the way for market launch of ViroCAP® in October 2025
Viromed Medical AG receives ISO 13485 certification, enabling market launch of ViroCAP® in October 2025 for dermatology, wound treatment, and veterinary use

Medical Devices ISO 13485 Certification Viromed Medical AG Market Launch ViroCAP
BRIEF

published on 07/29/2025 at 14:13, 9 months 3 days ago

Viromed Medical AG Approves Resolutions at Annual General Meeting

Annual General Meeting Supervisory Board Shareholder Resolutions Viromed Medical AG Cold Plasma Technology
PRESS RELEASE

published on 07/29/2025 at 14:08, 9 months 3 days ago

Viromed Medical AG: Annual General Meeting approves all proposed resolutions by a large majority
Viromed Medical AG's Annual General Meeting approves all proposed resolutions by a large majority. New Supervisory Board member elected, authorised capital replaced, and focus on innovation highlighted

Annual General Meeting Resolutions Strategic Direction Viromed Medical AG Cold Plasma Technology
BRIEF

published on 07/24/2025 at 09:35, 9 months 8 days ago

Viromed Medical AG Teams Up with TriPart for Product Launch in Turkey

Medical Devices Viromed Medical AG Cold Plasma Technology TriPart Partnership Market Expansion Turkey
PRESS RELEASE

published on 07/24/2025 at 09:30, 9 months 8 days ago

Viromed Medical AG enters into a distribution partnership with TriPart for the market launch of ViroCAP® and PulmoPlas® in Turkey
Viromed Medical AG partners with TriPart for market launch of ViroCAP® and PulmoPlas® in Turkey. New distribution agreement to introduce innovative medical technology products in Q1 2026

Distribution Partnership Viromed Medical AG ViroCAP PulmoPlas TriPart

Published on 05/02/2026 at 00:50, 15 minutes ago

CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 1 hour 5 minutes ago

Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 1 hour 5 minutes ago

Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/01/2026 at 22:30, 2 hours 35 minutes ago

Nextech3D.ai Appoints New Independent Auditor
Published on 05/01/2026 at 22:30, 2 hours 35 minutes ago

Integrated Rewards Achieves SOC 2 Compliance to Support Enterprise-Scale Growth Across Canada's Card-Linked Rewards Network as EQ Closes Convertible Debt Financing

View all ACCESSWIRE

Published on 05/01/2026 at 19:23, 5 hours 41 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 18:40, 6 hours 25 minutes ago

Holding(s) in Company
Published on 05/01/2026 at 17:47, 7 hours 18 minutes ago

Key Figures 30.04.2026
Published on 05/01/2026 at 17:45, 7 hours 19 minutes ago

Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)
Published on 05/01/2026 at 17:21, 7 hours 43 minutes ago

Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares

View all EQS

Published on 04/30/2026 at 20:00, 1 day 5 hours ago

AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 1 day 5 hours ago

AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 1 day 6 hours ago

Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 1 day 6 hours ago

Minutes of the Combined General Meeting held on April 30, 2026
Published on 04/30/2026 at 18:00, 1 day 7 hours ago

TF1 Q1 2026 results - Press release

View all LES ECHOS COMFI WIRE

News